Cochlear (STU:OC5) FFO


STU:OC5 Cochlear Ltd STU:OC5
60 GF Score
Price €71.21
GF Value €187.70
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Cochlear FFO?

FFO (Funds from operations) only applies to REITs.

STU:OC5
60GF Score
Cochlear Ltd STU:OC5
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cochlear (STU:OC5) Overvalued in 2026?

Based on GuruFocus' analysis, Cochlear stock appears to be undervalued. The current stock price of €71.21 is trading 62.1% below its estimated GF Value™ of €187.70. GuruFocus considers Cochlear to be Significantly Undervalued.

Key valuation signals for STU:OC5:

  • FFO:
  • GF Value™: €187.70 vs. price of €71.21 (62.1% below fair value)
  • GF Score™: 60/100 with 2 warning signs

No single metric tells the full story. See the STU:OC5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cochlear Business Description

Address 1 University Avenue, Macquarie University, Sydney, NSW, AUS, 2109
Cochlear is the leading cochlear implant device manufacturer, with around 60% global market share. Developed markets contribute 80% of group revenue, where cochlear implants are the standard of care for children with severe-to-profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2025, 49% of revenue came from the Americas, 34% from Europe, the Middle East, and Africa, and 18% from the Asia-Pacific segment.
60GF Score

Get the complete analysis for STU:OC5

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€71.21
Price
€187.70
GF Value